David Bell, CEO of a national workplace drug testing company, has called for mandatory drug testing for all government employees, arguing that the policy could address financial shortcomings and improve economic stability. Bell outlined his perspective in a recent opinion piece, linking substance abuse within high-ranking officials to wasteful spending and potential national security risks.
Highlighting the United States’ $36 trillion national debt, Bell focused on the financial impact of poor decision making, which he claims is exacerbated by substance abuse. The interest payments on our national debt now cost more than what the military spends, demonstrating how important it is to cut unnecessary spending.
Of course, Bell points out that drug testing requirements are already in place for safety-sensitive positions like military, law enforcement, and transportation jobs, under the Federal Drug-Free Workplace Program.
The program, established by Executive Order 12564, requires most federal employees, namely in the executive branch, to maintain a drug-free workplace and subjects them to random drug testing. Congressional staff likely fall under similar guidelines but policies may vary. They’re not currently subject to mandatory drug testing, but attempts to change this, such as the 2018 H.Con.Res.135, have failed to pass.
He suggests the requirement expand to include elected officials, judges, agency heads, and rank-and-file government employees. Why?
It’s no secret that Americans deal with substance abuse. The National Center for Drug Abuse Statistics shows that:
- Half of people 12 and older have used illegal narcotics at least once.
- Every year, more than 70,000 people die from drug overdose. Accidental overdose is the leading cause of death in people younger than 45.
- The drug overdose death rate increases at 4% annually.
Director of the National Institute on Drug Abuse (NIDA) Dr. Nora Volkow, says, “Our 50th year [as an organization] brought hope, as we finally saw evidence of a sustained downturn in drug overdose deaths. From July 2023 to July 2024, the number of fatal overdoses dropped nearly 17 percent, from over 113,000 to 94,000. We still don’t know all the factors contributing to this reversal, so investigating the drivers of this decline will be crucial for sustaining and accelerating the downturn. We also need to recognize that the decline is not homogenous across populations: Black and American Indian/Alaskan Native persons continue to die at increased rates. And 94,000 people dying of overdose in a year is still 94,000 too many. “
While we’re making progress on recovery and treatment at the national level, looking at where Washington D.C. fits into the picture, the statistics are alarming:
D.C. ranks 3rd highest in the nation for drug use and addiction, and drug health issues and rehab, according to a recent study. It’s tied with West Virginia for the highest number of overdose deaths per capita.
According to the Centers for Disease Control and Prevention (CDC), 451 people died of overdoses in 2022, at a rate of 67 overdose deaths per 100,000 people. Though the number itself is small compared to the total rate, it’s higher than the national average at 32.6 overdose deaths per 100,000 people. And it’s the highest rate since 1999 when data first became available.
Bell says, “While our elected officials and the bureaucrats who do their bidding have proven time and time again that they’re more than willing to spend our money irresponsibly, which is almost certainly driven to some degree by substance abuse, there’s an even more insidious risk lying just under the surface.”
Claiming that people with substance abuse disorder pose a threat to national security due to manipulation through blackmail for access to sensitive information or policy influence, Bell says that under the right conditions, the financial impact has the potential to devastate the economy.
Though the data isn’t there to determine how much of D.C.’s drug problem comes from civilians and how much comes from government officials, there are plenty of cases to support federal employees contributing to the drug abuse issues within D.C. and across the country.
In 2019, FBI agents arrested D.C. government employee Darrell Pope after executing a search warrant at the D.C. Department of Consumer and Regulatory Affairs (DCRA). Agents found 30 grams of what was suspected to be fentanyl. A search of his home in Clinton, Maryland revealed an ounce of fentanyl and three guns. Pope had been working for the DCRA since 2016.
In December 2020, he was convicted for selling 87 grams of fentanyl, enough for over 43,000 potentially lethal doses and was sentenced to 63 months in prison.
A House Ethics Committee report shows numerous allegations against former FL representative, Matt Gaetz. Though prosecutors didn’t charge him, the report details multiple crimes, including illicit drug use.
And former Florida representative Trey Radel was busted in a cocaine sting in 2013, pleading guilty to misdemeanor cocaine possession before resigning.
In December 2024, Special Agent David Cole of Homeland Security Investigations, was indicted on charges of conspiring with another agent to sell bath salts in Utah. Principal Deputy Attorney General Nicole M. Argentieri said, “The indictment alleges that David Cole abused his position as a federal law enforcement agent to obtain and sell dangerous drugs for profit. A drug dealer who carries a badge is still a drug dealer — and one who has violated an oath to uphold the law and protect the public.”
Bell also suggests the mandatory drug testing in combination with the Department of Government Efficiency (DOGE) findings to find and eliminate fraud and financial waste would provide a chance to pay down the national debt and restore economic stability to the citizens, rather than D.C. insiders.
He acknowledges the potential conflict of interest with his company, but maintains that while he may stand to benefit from such legislation, a program of the required scale would mean a much larger company would get the contract, and it’s his concern for the country’s financial future that drives his words.
Bell’s proposal raises complex issues surrounding privacy, ethics, and practicality. Critics might argue that mandatory drug testing across all levels of government is unrealistic, both from a legal and logistical point of view. Some may debate whether taking the steps would have any meaningful impact on the financial and institutional problems he highlights.
Regardless, Bell insists urgent action is necessary to reverse a dangerous fiscal situation. Though the proposed measure is controversial, it shows an ongoing dialogue about government accountability and actions we must take to secure a more stable economic future. Whether the initiative gains traction remains to be seen, but Bell’s arguments aim to spark further discussion about how to tackle America’s growing challenges.
